Arvinas (ARVN) Enterprise Value (2017 - 2026)
Arvinas' (ARVN) quarterly Enterprise Value came in at -$614.9 million in Q1 2026, up 35.57% year-on-year from -$453.6 million in Q1 2025, and up 10.29% quarter-over-quarter from -$685.4 million in Q4 2025.
Arvinas (ARVN) Enterprise Value (2017 - 2026) Analysis & Trends
Arvinas' Enterprise Value history runs 10 years deep, the most recent figure standing at -$614.9 million for Q1 2026.
- On a quarterly basis, Enterprise Value rose 35.57% year-over-year to -$614.9 million in Q1 2026; TTM through Mar 2026 was -$614.9 million, a 35.57% increase from a year earlier, with the FY2025 full-year figure at -$685.4 million, up 34.06% from the prior year.
- Enterprise Value rose to -$614.9 million in Q1 2026 per ARVN's latest filing, from -$685.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$66.8 million in Q1 2022 and bottomed at -$1.2 billion in Q1 2024.
- The 5-year median for Enterprise Value is -$160.3 million (2024), against an average of -$436.2 million.
- Across the five-year window, Enterprise Value surged 91.06% in 2022 and slumped 824.41% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$86.8 million in 2022, then plunged by 265.44% to -$317.2 million in 2023, then sank by 227.68% to -$1.0 billion in 2024, then soared by 34.06% to -$685.4 million in 2025, then increased by 10.29% to -$614.9 million in 2026.
- Per Business Quant, the three latest ARVN Enterprise Value figures stand at -$614.9 million (Q1 2026), -$685.4 million (Q4 2025), and -$787.6 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - | -614.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -614.90 Mn |
| Dec 31, 2025 | -685.40 Mn |
| Sep 30, 2025 | -787.60 Mn |
| Jun 30, 2025 | -861.20 Mn |
| Mar 31, 2025 | -954.30 Mn |
| Dec 31, 2024 | -1.04 Bn |
| Sep 30, 2024 | -85.20 Mn |
| Jun 30, 2024 | -160.30 Mn |
| Mar 31, 2024 | -1.17 Bn |
| Dec 31, 2023 | -317.20 Mn |
| Sep 30, 2023 | -119.20 Mn |
| Jun 30, 2023 | -96.10 Mn |
| Mar 31, 2023 | -135.70 Mn |
| Dec 31, 2022 | -86.80 Mn |
| Sep 30, 2022 | -138.10 Mn |
| Jun 30, 2022 | -97.70 Mn |
| Mar 31, 2022 | -66.80 Mn |
| Dec 31, 2021 | -112.80 Mn |
| Sep 30, 2021 | -1.54 Bn |
| Jun 30, 2021 | -53.23 Mn |